Related Experiment Video
Updated: May 22, 2025
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
7.7K
Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation
Ville Liukkonen1, Maria Semenova2, Kati Hyvärinen2
1North Karelia Central Hospital, Gastroenterology, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
Summary
Genetic factors influence steatotic liver disease (SLD) after liver transplantation (LT). Donor PNPLA3 rs738409-G is a significant risk allele, but genetic data offers modest predictive value over clinical factors.
Area of Science:
- Hepatology
- Transplantation Medicine
- Genetics
Background:
- Steatotic liver disease (SLD) following liver transplantation (LT) is a growing concern.
- Both donor and recipient genetic factors are suspected to influence post-LT SLD.
- Limited research exists on the genetic underpinnings of post-LT SLD.
Purpose of the Study:
- To investigate the incidence and risk factors for post-LT SLD.
- To evaluate the impact of 56 SLD-associated genetic variants in donor-recipient pairs.
- To determine if a polygenic risk score (PRS-5) enhances SLD prediction.
Main Methods:
- Analysis of 595 donor-recipient pairs with liver biopsy data ≥6 months post-LT.
- Assessment of 56 single nucleotide polymorphisms (SNPs) associated with SLD.
- Multivariate analysis incorporating genetic variants and non-genetic risk factors.
Main Results:
- SLD was diagnosed in 34.5% of patients post-LT.
- Significant genetic risk factors identified include donor PNPLA3 rs738409-G and recipient UCP2 rs695366-G.
- The addition of PRS-5 modestly improved SLD prediction (AUC 0.78 to 0.80).
Conclusions:
- Genetic variants in both donors and recipients contribute to post-LT SLD.
- Donor PNPLA3 rs738409-G is a key genetic risk factor.
- Genotyping offers limited additional predictive value beyond clinical data, emphasizing modifiable factors.
